BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• InnoCare and Keymed Jointly Announce First Subject Dosed in Clinical Trial of CCR8 Monoclonal Antibody ICP-B05

  InnoCare Pharma and Keymed Biosciences jointly announced that the first subject has been dosed in clinical trial of ICP-B05, an anti-CC chemokine receptor 8 monoclonal antibody, developed by a joint venture between the two companies called Tiannuojiancheng Pharma in China.

  February 23, 2023

   · 

  3 min read
• Cingulate Announces Positive Top-Line Results from Fed/Fast Study of Lead Asset CTx-1301 for ADHD

  Cingulate Inc. today announced positive top-line results from the CTx-1301-003 study.

  February 23, 2023

   · 

  8 min read
• Business

  SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023

  SOPHiA GENETICS today announced it will release its financial results for the fourth quarter and full year of fiscal 2022 before U.S. markets open on Tuesday, March 7, 2023.

  February 23, 2023

   · 

  1 min read
• Drug Development

  Nektar Therapeutics Announces Phase 2 Topline Data for Rezpegaldesleukin in Patients with Systemic Lupus Erythematosus

  Nektar Therapeutics (Nasdaq: NKTR) today announced topline data from a Phase 2 randomized, double-blind, placebo-controlled study of rezpegaldesleukin.

  February 23, 2023

   · 

  10 min read
• Business

  Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2022 Results

  Apollo Medical Holdings, Inc. today announced its consolidated financial results for the fourth quarter and year ended December 31, 2022.

  February 23, 2023

   · 

  20 min read
• Business

  Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2022 and Cash Dividend

  Select Medical Holdings Corporation announced results for its fourth quarter and year ended December 31, 2022 and the declaration of a cash dividend.

  February 23, 2023

   · 

  36 min read
• Accelerating Innovation for the Spinal Cord Injury Community

  Praxis Spinal Cord Institute is pleased to announce the three transformative technologies selected as the SCI Incubate program cohort for 2023.

  February 23, 2023

   · 

  3 min read